This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pichichero, M. E. Search for Related Content PubMed PubMed Citation Articles by Pichichero, M. E. Pubmed/NCBI databases Medline Plus Health Information Cervical Cancer HPV Immunization Social Bookmarking                         What's this?

Prevention of Cervical Cancer Through Vaccination of Adolescents

Department of Microbiology and Immunology, Pediatrics, and Medicine, University of Rochester Medical Center, Elmwood Pediatric Group, Rochester, New York.

References

• HPV vaccines hold promise for reducing cervical cancer. Available at general-medicine.jwatch.org/cgi/content/full/2005/1230/10. Accessed April 2, 2006.
• American Cancer Society. Estimated new cancer cases and deaths by sex for all sites, US, 2006. Available at http://www.cancer.org/downloads/stt/CAFF06EsCsMc.pdf. Accessed March 17, 2006.
• Centers for Disease Control and Prevention. Genital HPV Infection Fact Sheet. Rockville, Md: CDC National Prevention Information Network; 2004.
• Cates W Jr, and the American Social Health Association Panel. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex Transm Dis. 1999;26(suppl):S2-S7.[Web of Science][Medline] [Order article via Infotrieve]
• Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36:6-10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Burk RD, Ho GYF, Beardsley L, Lempa M, Peters M, Bierman R. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J Infect Dis. 1996;174:679-689.[Web of Science][Medline] [Order article via Infotrieve]
• Bauer HM, Ting Y, Greer CE, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA. 1991;265:472-477.[Abstract/Free Full Text]
• de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology. 2004; 324:17-27.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Howley PM. Papillomavirinae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology. 3rd ed. Philadelphia, Pa: Lippincott-Raven; 1996;2045-2076.
• Jansen KU, Shaw AR. Human papillomavirus vaccines and prevention of cervical cancer. Annu Rev Med. 2004; 55:319-331.[CrossRef][Medline] [Order article via Infotrieve]
• Schiffman M, Castle PE. Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med. 2003;127:930-934.[Web of Science][Medline] [Order article via Infotrieve]
• Wiley DJ, Douglas J, Beutner K, et al. External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis. 2002;36(suppl 2):S210-S224.
• Stone KM, Karem KL, Sternberg MR, et al. Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis. 2002;186:1396-1402.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Sinclair KA, Woods CR, Kirse DJ, Sinal SH. Anogenital and respiratory tract human papillomavirus infections among children: age, gender, and potential transmission through sexual abuse. Pediatrics. 2005;116:815-825.[Abstract/Free Full Text]
• Gonzalez Intxaurraga MA, Stankovic R, Sorli R, Trevisan G. HPV and carcinogenesis. Acta Dermatovenerol. 2002;1:1-8.[Medline] [Order article via Infotrieve]
• Winer RL, Lee SK, Hughes JP, et al. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. 2003;157:218-226.[Abstract/Free Full Text]
• Fairley CK, Gay NJ, Forbes A, Abramson M, Garland SM. Hand-genital transmission of genital warts? An analysis of prevalence data. Epidemiol Infect. 1995;115:169-176.[Medline] [Order article via Infotrieve]
• Herrero R, Castellsague X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003;95:1772-1783.[Abstract/Free Full Text]
• Armbruster-Moraes E, Ioshimoto LM, Leao E, Zugaib M. Presence of human papillomavirus DNA in amniotic fluids of pregnant women with cervical lesions. Gynecol Oncol. 1994;54:152-158.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Rintala MA, Grenman SE, Jarvenkyla ME, Syrjanen KJ, Syrjanen SM. High-risk types of human papillomavirus (HPV) DNA in oral and genital mucosa of infants during their first 3 years of life: experience from the Finnish HPV Family Study.Clin Infect Dis. 2005;41:1728-1733.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Sinal SH, Woods CR. Human papillomavirus infections of the genital and respiratory tracts in young children. Semin Pediatr Infect Dis. 2005;16:306-316.[Medline] [Order article via Infotrieve]
• Insinga RP, Dasbach EF, Myers ER. The health and economic burden of genital warts in a set of private health plans in the United States.Clin Infect Dis. 2003;36:1397-1403.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Svare EI, Kjaer SK, Worm AM, Osterlind A, Meijer CJ, van den Brule AJ. Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect. 2002;78:215-218.[Abstract/Free Full Text]
• Murthy NS, Mathew A. Risk factors for pre-cancerous lesions of the cervix. Eur J Cancer Prev. 2000;9:5-14.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Centers for Disease Control and Prevention. Genital HPV infection—CDC fact sheet. Available at www.cdc.gov/std/HPV/STDFact-HPV.htm. Accessed March 31, 2006.
• Meijer CJLM, Helmerhorst TJM, Rozendaal L, van der Linden JC, Voorhorst FJ, Walboomers JMM. HPV typing and testing in gynaecological pathology: has the time come? Histopathology. 1998;33:83-86.[Medline] [Order article via Infotrieve]
• Ho L, Terry G, Londesborough P, Cuzick J, Lorenzato F, Singer A. Human papillomavirus DNA detection in the management of women with twice mildly abnormal cytological smears.J Med Virol. 2003;69:118-121.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;12;338:423-428.
• Hildesheim A, Herrero R, Castle PE, HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer. 2001;84:1219-1226.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kobayashi A, Greenblatt RM, Anastos K, et al. Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection. Cancer Res. 2004;64:6766-6774.[Abstract/Free Full Text]
• Pinto AP, Crum CP. Natural history of cervical neoplasia: defining progression and its consequence. Clin Obstet Gynecol. 2000;43:352-362.[CrossRef][Medline] [Order article via Infotrieve]
• Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ. HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol. 2006; 208(2): 152-164.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Crum CP, Rivera MN. Vaccines for cervical cancer. Cancer J. 2003;9:368-376.[Medline] [Order article via Infotrieve]
• Parham GP. Comparison of cell collection and direct visualization cervical cancer screening adjuncts. Am J Obstet Gynecol. 2003;188:S13-S20.[Medline] [Order article via Infotrieve]
• Schink JC. Strategies for detecting cervical dysplasia: visual inspection, spectroscopy, and speculoscopy. OBG Management. 2003;(suppl):5-8.
• Uyar DS, Eltabbakh GH, Mount SL. Positive predictive value of liquid-based and conventional cervical Papanicolaou smears reported as malignant. Gynecol Oncol. 2003;89:227-232.[Medline] [Order article via Infotrieve]
• Kulasingam SL, Hughes JP, Kiviat NB, et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA. 2002;288:1749-1757.[Abstract/Free Full Text]
• Selvaggi SM. Implications of low diagnostic reproducibility of cervical cytologic and histologic diagnoses. JAMA. 2001;285:1506-1508.[Free Full Text]
• Chacho MS, Mattie ME, Schwartz PE. Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: a comparison.Cancer. 2003;99:135-140.[Medline] [Order article via Infotrieve]
• Zhou J, Sun XY, Stenzel DJ, Frazer IH. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology. 1991;185:251-257.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hagensee ME, Yaegashi N.Galloway DA. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J Virol. 1993;67:315-322.[Abstract/Free Full Text]
• Frazer IH, Cox JT, Mayeaux Jr EJ, et al. Advances in prevention of cervical cancer and other human papillomavirus-related diseases. Pediatr Infect Dis J. 2006;25:S65-S81.[CrossRef][Medline] [Order article via Infotrieve]
• Harro CD, Pang YY, Roden RB, et al. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J Natl Cancer Inst. 2001;93:284-292.[Abstract/Free Full Text]
• Evans TG, Bonnez W, Rose RC, A Phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers. J Infect Dis. 2001;183:1485-1493.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Harper DM, Franco EL, Wheeler C, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomized controlled trial. Lancet. 2004;364:1757-1765.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Harper DM, Franco EL, Wheeler CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. 2006; 367:1247-1255.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005;6:271-278.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Bonnez W. Immunization against genital human papillomaviruses. J Infect Dis J. 2005;24:1005-1006.
• Goldie SJ, Kohli M, Grimm D, et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst. 2004;96:604-615.[Abstract/Free Full Text]
• Zimet GD. Understanding and overcoming barriers to human papillomavirus vaccine acceptance. Curr Opin Obstet Gynecol. 2006;18(suppl 1):S23-S28.[Medline] [Order article via Infotrieve]
• Clements CJ, Abdool-Karim Q, Chang ML, Nkowane B, Esparza J. Breaking new ground3/4are changes in immunization services needed for the introduction of future HIV/AIDS vaccines and other new vaccines targeted at adolescents?Vaccine. 2004;22:2822-2826.[Medline] [Order article via Infotrieve]

Clinical Pediatrics, Vol. 45, No. 5, 393-398 (2006)
DOI: 10.1177/0009922806289907


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pichichero, M. E. Search for Related Content PubMed PubMed Citation Articles by Pichichero, M. E. Pubmed/NCBI databases Medline Plus Health Information Cervical Cancer HPV Immunization Social Bookmarking                         What's this?